2005
DOI: 10.1111/j.1399-6576.2004.00591.x
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively

Abstract: IgE-sensitization to SUX, MOR and PHO was detected in Norway but not in Sweden. One possible explanation is the unrestricted use of cough mixtures containing MOR derivatives in Norway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
105
1
8

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 145 publications
(118 citation statements)
references
References 18 publications
4
105
1
8
Order By: Relevance
“…(7) To assist anaesthetists to provide appropriate information to the specialist centre. (8) To make recommendations about the reporting and collection of data on anaesthetic anaphylaxis in Great Britain and Ireland.…”
Section: Objectivesmentioning
confidence: 99%
See 3 more Smart Citations
“…(7) To assist anaesthetists to provide appropriate information to the specialist centre. (8) To make recommendations about the reporting and collection of data on anaesthetic anaphylaxis in Great Britain and Ireland.…”
Section: Objectivesmentioning
confidence: 99%
“…The prevalence of anaphylactic reactions to neuromuscular blocking agents (NMBAs) is reported to be at least six times more frequent in some countries [7,8]: it is considerably more common in Norway than in Sweden. Quaternary ammonium ions (QAI) are proposed to be the allergenic epitopes in NMBAs.…”
Section: Possible Environmental Sensitising Agentsmentioning
confidence: 99%
See 2 more Smart Citations
“…There are currently no NMBA-specific IgE assays readily available, except for suxamethonium (Phadia c202). Unfortunately, on several occasions, sIgE for suxamethonium has been reported to be too insensitive (sensitivity 30-60%) (15,56,57). Different authors have proposed to use a quaternary ammonium (choline chloride) (9,14,(58)(59)(60), a p-aminophenylphosphoryl-choline (15, 61), or morphine-based solid phase sIgE (15,56) assay in preference to different NMBA-specific IgE assays to assess sensitization from quaternary ammonium determinants of NMBA.…”
Section: Neuromuscular Blocking Agentsmentioning
confidence: 99%